Correlation Between Vor Biopharma and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vor Biopharma and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Vor Biopharma and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Anebulo Pharmaceuticals.

Diversification Opportunities for Vor Biopharma and Anebulo Pharmaceuticals

0.45

Correlation Coefficient

Vor Biopharma  Anebulo Pharmaceuticals

Very weak diversification

The 3 months correlation between Vor and Anebulo is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vor Biopharma and Anebulo Pharmaceuticals

Considering the 90-day investment horizon Vor Biopharma is expected to generate 3.91 times less return on investment than Anebulo Pharmaceuticals. In addition to that, Vor Biopharma is 1.21 times more volatile than Anebulo Pharmaceuticals. It trades about 0.03 of its total potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.13 per unit of volatility. If you would invest  111.00  in Anebulo Pharmaceuticals on December 19, 2024 and sell it today you would earn a total of  66.00  from holding Anebulo Pharmaceuticals or generate 59.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vor Biopharma  vs.  Anebulo Pharmaceuticals

Vor Biopharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vor Biopharma and Anebulo Pharmaceuticals

The main advantage of trading using opposite Vor Biopharma and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Vor Biopharma and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.